58
TM. Epicutaneus allergen-specific
immunotherapy ameliorates grass
pollen-induced rhinoconjunctivi-
tis: A double-blind, placebo con-
trolled dose escalation study. J
Allergy Clin Immunol 2012;129:
128-35
44.
Mondoulet L, Dioszeghy V, Li-
gouis M, Dhelft V, Puteaux E, Du-
pont C, Benhamou PH. Epicuta-
neus Immunotherapy compared
with sublingual Immunotherapy
in mice sensitized to pollen (Phe-
lum pratense). ISRN Allergy 2012;
2012:e375735
45.
Dupont C, Kalach N, Soulaines P,
Legoué-Morillon S, Piloquet H, Ben-
hamou PH. Cow`s milk epicutaneus
immunotherapy in children: a pilot
trail of safety acceptability, and im-
pact on allergy reactivity. J Allergy
Clin Immunol 2010;125:1165-7
46.
Martinez-Gomez J, Johansen P,
Erdmann I, Senti G, Cremari R,
Kündig TM. Intralymphalic injec-
tion as a new administration route
for allergen specific immunothe-
rapy. Into Arch Allergy Immunol
2009;150:59-65
47.
Senti G, Crameri R, Kuster D, Johan-
sen P, Martinez-Gomez JM et al. In-
tralymphatic immnutherapy for cat
allergy induces tolerance after only
3 injections. J Allergy Clin Immunol
2012;129: 1290-6
juvants enhance sublin- gual im-
munotherapy efficacy in a murine
asth- ma model. Int Arch Allergy Im-
munol 2008; 145:152-62;
38.
De Souza Rebouças J, Esparza I,
Ferrer M, Sanz ML, Irache JM, Ga-
mazo C. Nanoparticulate adjuvants
and delivery systems for allergen
immunotherapy. J Biomed Biotech-
nol 2012; 2012:474605;
39.
Basomba A, Tabar AI, Hernandez
D, et al. Allergen vaccination with
liposome-encapsulated extract of
Dermatophagoides
pteronyssi-
nus: a ramdomized, doublé blind
placebo controlled trial in asthma-
tic patiens. J allergy Clin Immunol
2002;109;943-948
40.
Kupper TS, Fuhlbrigge RC. Immune
surveillance in the skin:mechanism
and clinical consequences. Nat Rev
Immunol 2004;4:211-22
41.
FrerichsDM,EllingsworthLR, FrechSA,
Flyer DC,Villar CP,Yu J et al. Controlled,
single-step, stratum corneo disruption
as a pretreatment for immunization
via pach.Vaccine 2008;26:2782-7
42.
Senti G, Graf N, Haug S, Rüedy N,
von Moos S, Sonderegger T, et al.
Epicutaneus allergen administra-
tion as a novel method of allergen-
specific immunotherapy. J Allergy
Clin Immunol 2009;124:997-1002
43.
Senti G, von Moos S, Tay F, Graf N,
SondereggerT, Johansen P, Kündig
Nuevas modalidades de inmunoterapia en niños
